These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 2305180

  • 1. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.
    García-Rodríguez JE, García-Sánchez JE.
    Rev Infect Dis; 1990; 12 Suppl 2():S142-51. PubMed ID: 2305180
    [Abstract] [Full Text] [Related]

  • 2. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH, Kim S, Kim CK, Yum JH, Kim MS, Yong D, Lee K, Kim JM, Chong Y.
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [Abstract] [Full Text] [Related]

  • 3. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
    Betriu C, Cabronero C, Gomez M, Picazo JJ.
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757
    [Abstract] [Full Text] [Related]

  • 4. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 5. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C, Sánchez A, Gómez M, Palau ML, Picazo JJ.
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L, Castello L, Di Martino A, Greco G, Legaria MC, Litterio M, Predari SC, Rollet R, Rossetti A, Carloni G, Sarchi MI, Bianchini H.
    Rev Argent Microbiol; 2007 Jan; 39(3):156-60. PubMed ID: 17987852
    [Abstract] [Full Text] [Related]

  • 7. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
    Teng LJ, Hsueh PR, Tsai JC, Liaw SJ, Ho SW, Luh KT.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
    [Abstract] [Full Text] [Related]

  • 8. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
    Borobio MV, Domínguez MC, Pallares JA, Perea EJ.
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
    De Almeida AE, De Uzeda M.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
    [Abstract] [Full Text] [Related]

  • 10. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
    Betriu C, Campos E, Cabronero C, Rodriguez-Avial C, Picazo JJ.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):671-3. PubMed ID: 2344174
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
    Jamal W, Khodakhast FB, AlAzmi A, Sόki J, AlHashem G, Rotimi VO.
    BMC Microbiol; 2020 Jan 15; 20(1):14. PubMed ID: 31941446
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of the Bacteroides fragilis group in the United States in 1981.
    Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleary TJ, Finegold SM, Hill GB, Iannini PB, McCloskey RV, O'Keefe JP, Pierson CL.
    Antimicrob Agents Chemother; 1983 Apr 15; 23(4):536-40. PubMed ID: 6859833
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.
    Phillips I, King A, Nord CE, Hoffstedt B.
    Eur J Clin Microbiol Infect Dis; 1992 Apr 15; 11(4):292-304. PubMed ID: 1396748
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.
    Watanabe K, Ueno K, Kato N, Muto Y, Bandoh K, Tanaka Y, Jotwani R, Goto M, Shimada K, Shimizu K.
    Eur J Clin Microbiol Infect Dis; 1992 Nov 15; 11(11):1069-73. PubMed ID: 1295761
    [Abstract] [Full Text] [Related]

  • 15. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
    Lee K, Chong Y, Jeong SH, Xu XS, Kwon OH.
    Clin Infect Dis; 1996 Dec 15; 23 Suppl 1():S73-7. PubMed ID: 8953110
    [Abstract] [Full Text] [Related]

  • 16. Survey of Bacteroides fragilis group susceptibility patterns in Canada.
    Bourgault AM, Lamothe F, Hoban DJ, Dalton MT, Kibsey PC, Harding G, Smith JA, Low DE, Gilbert H.
    Antimicrob Agents Chemother; 1992 Feb 15; 36(2):343-7. PubMed ID: 1605600
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center.
    Appleman MD, Heseltine PN, Cherubin CE.
    Rev Infect Dis; 1991 Feb 15; 13(1):12-8. PubMed ID: 2017610
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.
    Schaumann R, Funke M, Janssen E, Rodloff AC.
    Antimicrob Agents Chemother; 2012 Jun 15; 56(6):3413-6. PubMed ID: 22430962
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW, Weeks LS, Aldridge KE.
    Diagn Microbiol Infect Dis; 1991 Jun 15; 14(5):377-82. PubMed ID: 1797454
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Downes J, Andrew JH.
    Pathology; 1988 Jul 15; 20(3):260-3. PubMed ID: 3205597
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.